Update from listening to the CDC ACIP meeting on the J&J vaccine:
They postponed making any decision, effectively continuing the pause on use of the vaccine.
They will reconvene in 7-10 days to review case reports from the ~4M who received the vax in last two weeks.
Why wait for more info? A new case of cerebral sinus venus thrombosis was reported in a 25 year old man who became critically ill from a cerebral hemorrhage.
And for women age 20-50, CSVT occurred in 1 in 13,000, or 4-15X higher than background.
My guess is that additional data and a full risk analysis will support a recommendation that women <50 get mRNA vaccines unless no other choice, but for people >50, J&J is fine.
What the story in young males will be remains to be seen.
I was on the fence on this. I'm not anymore. Here's why.
1. More contagious strains are now >1/3 of all US cases. And new evidence confirms B117 causes more severe disease, with MUCH higher rates of severe illness and death at younger ages. directorsblog.nih.gov/author/collins…
2. Rising cases require more commitment to masks, testing, indoor limits. But the recurring pattern here and abroad is many people and local leaders won't tighten these until too late.
Cases are now climbing again in a majority of states--esp across the northeast and midwest.
@CDCDirector Walensky is right to be sounding the alarm. This is how surges start.
We are a few weeks behind the pattern of the surges now happening in Europe, Asia, and South America.
In the last week, US hospitalizations have started to climb, as well. And cases are up despite a marked drop in testing. washingtonpost.com/graphics/2020/…
I know COVID seems like it is subsiding. But the B117 variant is spreading. What we do now to stop it determines whether it takes over and fills hospitals again in 2 months.
1. We need all Americans to wear a high quality mask. Upgrading to one with a metal nose clip and a snug fit so it doesn't fall when you talk or leak so much out the sides--ideally a medical grade mask--is important. This variant is 30-50% more contagious than what we've faced.
2. We must keep avoiding socializing indoors in groups (eg >10 people). While overall COVID rates are falling, B117 variant is doubling every 10 days. It was 4.5% of all cases in Florida last week--and expected to be the majority in early March. sciencealert.com/uk-coronavirus…
Pfizer's move is indefensible. Yes, squeeze every dose we can. But cutting deliveries from 40M to 33M vials for the same price cannot be justified. Especially when many places lack the special "low dead space" syringes needed to get the "extra" dose. nytimes.com/2021/01/22/hea…
"The world’s largest syringe maker does not have the capacity to substantially increase U.S. supplies of specialty syringes needed to squeeze more doses from Pfizer's vaccine vials in the coming weeks, an executive said." reuters.com/article/us-hea…
This image was very helpful for me to understand the difference between low dead space syringes and needles from the standard ones. (Thanks Harm Reduction Journal and whomever thought to come up with such a publication.) harmreductionjournal.biomedcentral.com/articles/10.11…
Key findings from the latest Axios-Ipsos Coronavirus poll.
1. Americans are more worried about COVID's impact on their health, job, and finances than since June. And for most, out of home activity is declining accordingly. axios.com/axios-ipsos-po…
2. Vaccine interest is up, with most now saying they are likely to take a COVID-19 vaccine if it public health officials say it is safe and effective (69%), has a 90%+ effectiveness rate (67%), or has been on the market a few months (65%). ipsos.com/en-us/news-pol…
3. A small minority of people (18%) are driving most of the indoor activity outside the home that drives spread. Only 44% of this group wear a mask when outside home and only 36% are very concerned about the virus. These are the folks (more male, <55, GOP) whose help we need.
Spoke to @MarketWatch and here are a few of the points I made:
- Today's election determines who's in charge Jan 20, but what happens with addressing the major surge of COVID19 cases and hospitalizations and with vaccines is being determined now. marketwatch.com/story/dr-gawan…
- If we get an effective vaccine, the big problem won't be hesitancy, but lack of supply and distribution resources forcing hard choices among priority groups.
- We will need a mass movement to back mask-wearing, far more testing, and open hospital data.
- And, finally, if Trump holds onto power, we cannot give up hope. We still have ways for states, Congress, and the public to fight the virus even if this administration won't. We still have ways to not let doctors and science become demonized.